TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 1 filers reported holding TANGO THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,305 | +71.2% | 1,448 | -49.5% | 0.00% | – |
Q2 2023 | $9,525 | +18217.3% | 2,869 | -78.5% | 0.00% | -100.0% |
Q1 2023 | $52 | +126.1% | 13,323 | +313.5% | 0.00% | +100.0% |
Q4 2022 | $23 | -99.8% | 3,222 | -0.6% | 0.00% | – |
Q3 2022 | $12,000 | +20.0% | 3,240 | +46.5% | 0.00% | – |
Q2 2022 | $10,000 | +900.0% | 2,212 | +2112.0% | 0.00% | – |
Q1 2022 | $1,000 | -90.9% | 100 | -87.9% | 0.00% | – |
Q3 2021 | $11,000 | – | 828 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 19,363,975 | $146,779,000 | 53.77% |
TCG Crossover Management, LLC | 1,254,500 | $9,509,000 | 3.82% |
Cormorant Asset Management, LP | 4,899,185 | $37,136,000 | 2.85% |
Boxer Capital, LLC | 6,871,642 | $52,087,000 | 2.68% |
Casdin Capital, LLC | 5,487,910 | $41,598,000 | 1.86% |
Bain Capital Life Sciences Investors, LLC | 1,921,790 | $14,567,000 | 1.42% |
Samsara BioCapital, LLC | 630,000 | $4,775,000 | 1.20% |
TANG CAPITAL MANAGEMENT LLC | 468,750 | $3,553,000 | 0.71% |
Southpoint Capital Advisors LP | 3,805,929 | $28,849,000 | 0.56% |
HARVARD MANAGEMENT CO INC | 708,385 | $5,370,000 | 0.54% |